💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for N/A

No earnings history available for this symbol.

📰 Related News & Research

• CytoDyn Inc. 2026 Q3 10-Q Report: Financial Results, Stockholder Deficit, and Company Overview
  April 8, 2026
  

  CytoDyn Inc. Q3 2026 Investor Update: Key Financial and Corp...

• Yum China Holdings, Inc. Files 8-K Announcing 2025 Annual Report Release and Key Company Information
  April 8, 2026
  

  Yum China Holdings, Inc. Files Form 8-K and Releases Annual ...

• Patriot National Bancorp, Inc. Files Form 8-K Current Report with SEC – April 2026 Company Information and Key Details
  April 8, 2026
  

  Patriot National Bancorp, Inc. Announces Executive Departure...

• Jabil Inc. Q2 2026 Financial Results: Earnings, Revenue, and Key SEC Filings Overview
  April 8, 2026
  

  Jabil Inc. Q2 2026 Financial Report: In-depth Investor Analy...

• AXIL Brands, Inc. (NYSE: AXIL) Reports Q3 2026 Financial Results and Quarterly Performance Highlights
  April 8, 2026
  

  Axil Brands, Inc. Q3 2026 Earnings Report: Key Highlights an...

• FactSet Appoints Joshua B. Warren as New Chief Financial Officer, Succeeding Helen Shan
  April 8, 2026
  

  FactSet Announces CFO Transition: What Investors Need to Kno...

• Plus Therapeutics Receives FDA Orphan Drug Designation for REYOBIQ™ in Pediatric Malignant Gliomas and Ependymoma
  April 8, 2026
  

  Plus Therapeutics Secures FDA Orphan Drug Designation for RE...

• AquaBounty Technologies Announces Series A Convertible Preferred Stock Designation and Securities Exchange Agreement – SEC Filing April 2026
  April 8, 2026
  

  AquaBounty Technologies Announces \$5 Million Series A Conve...

• AXIL Brands Reports Q3 2026 Financial Results: Revenue Growth, Retail Expansion, and Fiscal Year Outlook
  April 8, 2026
  

  AXIL Brands, Inc. Q3 2026 Financial Results - Investor Updat...

• Nurix Therapeutics, Inc. Q1 2026 Financial Results: Continued R&D Investment, Collaboration Revenue, and Key Risk Factors Highlighted in 10-Q Filing
  April 8, 2026
  

  Nurix Therapeutics, Inc. Q1 2026 Financial Report: Key Inves...

🔍 View more Reports